Perspective Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 114.26 | -100% | -13.15 | -100% |
| P/S |
|
133.02 | 4.1 | 3142% |
|
|
| P/BV |
|
17.29 | 9.02 | 91.65% |
|
|
| P/FCF |
|
0 | 44.54 | -100% |
|
|
| Ev/Ebitda |
|
-62.27 | 17.72 | -451.42% |
|
|
| Ev/S |
|
130.07 | 4.4 | 2853.08% |
|
|
| Ev/FCF |
|
-74.07 | 54.7 | -235.42% |
|
|
| E/P |
|
0 | 0.2136 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-208.87 | 21.49 | -1072.04% | -110.78 | +88.54% |
| ROE |
|
-26.85 | -82.41 | -67.42% |
|
|
| ROA |
|
-25.25 | 6.75 | -474.08% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-206.5 | 10.29 | -2107.12% |
|
|
| ROCE |
|
-27.78 | 55.43 | -150.12% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1163 | 0.9571 | -112.15% | -0.1194 | -2.67% |
| Nеt Debt/Ebitda |
|
1.41 | 2.1 | -32.48% |
|
|
| Debt/Ratio |
|
0.0297 | 0.2655 | -88.81% |
|
|
| Debt/Equity |
|
0 | 4.83 | -100% |
|
|
| Debt/Net Income |
|
-0.1176 | 35.64 | -100.33% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.31 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.35 | -100% | ||
| DSI |
|
0 | 0.7501 | -100% |
|
|
| Average dividend growth |
|
0 | -0.7622 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.28 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.77 | -100% |
|
|
| Difference from average difference in sector |
|
-1.31 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-2.68 | 214.83 | -101.25% | ||
| Growth impulse Ebitda in 5 years |
|
179.96 | 253.48 | -29% | ||
| Growth impulse Net Income in 5 years |
|
199.39 | 270.34 | -26.24% | ||
| Growth impulse FCF in 5 years |
|
126.8 | 183.09 | -30.74% | ||
| Growth impulse EPS in 5 years |
|
42.79 | 149.95 | -71.46% |
IP Score
3.54/10
